The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes. 
The announcement comes just two weeks after Merck pulled its painkiller from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer.
